Cost impact of trastuzumab prescribing in the treatment of advanced Her2 positive gastric cancer in Ireland

Collins, Ian M., King, F., & O'Byrne, Kenneth J. (2012) Cost impact of trastuzumab prescribing in the treatment of advanced Her2 positive gastric cancer in Ireland. Irish Journal of Medical Science, 181(3), pp. 451-452.

View at publisher

Impact and interest:

0 citations in Scopus
Search Google Scholar™

Citation counts are sourced monthly from Scopus and Web of Science® citation databases.

These databases contain citations from different subsets of available publications and different time periods and thus the citation count from each is usually different. Some works are not in either database and no count is displayed. Scopus includes citations from articles published in 1996 onwards, and Web of Science® generally from 1980 onwards.

Citations counts from the Google Scholar™ indexing service can be viewed at the linked Google Scholar™ search.

ID Code: 64905
Item Type: Journal Article
Refereed: Yes
Additional Information: Letter to the editor
Additional URLs:
Keywords: antineoplastic agent, epidermal growth factor receptor 2, trastuzumab, drug cost, esophagus cancer, gene amplification, health care delivery, human, immunohistochemistry, Ireland, letter, major clinical study, overall survival, quality of life, stomach cancer, Antibodies, Monoclonal, Humanized, Antineoplastic Agents, Esophageal Neoplasms, Humans, Quality-Adjusted Life Years, Receptor, erbB-2, Stomach Neoplasms
DOI: 10.1007/s11845-011-0772-7
ISSN: 0021-1265
Divisions: Current > Schools > School of Biomedical Sciences
Current > QUT Faculties and Divisions > Faculty of Health
Current > Institutes > Institute of Health and Biomedical Innovation
Copyright Owner: Copyright 2012 Springer U K
Deposited On: 29 Nov 2013 04:43
Last Modified: 18 Dec 2013 04:37

Export: EndNote | Dublin Core | BibTeX

Repository Staff Only: item control page